Search :
Sign in or Register  
Welcome Sign in or Don't have an account?Register

Mouse Anti-HSPB1 Recombinant Antibody (CB483A) (CBMAB-CA483LY)


See all HSPB1 antibodies
Online Inquiry

Summary

Host Animal
Mouse
Specificity
Human
Clone
CB483A
Antibody Isotype
IgG
Application
ELISA, WB, IHC

Basic Information

Immunogen
Recombinant Protein
Specificity
Human
Antibody Isotype
IgG
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Buffer
50% Glycerol
Preservative
0.02% sodium azide
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Target

Full Name
heat shock protein family B (small) member 1
Introduction
This gene encodes a member of the small heat shock protein (HSP20) family of proteins. In response to environmental stress, the encoded protein translocates from the cytoplasm to the nucleus and functions as a molecular chaperone that promotes the correct folding of other proteins. This protein plays an important role in the differentiation of a wide variety of cell types. Expression of this gene is correlated with poor clinical outcome in multiple human cancers, and the encoded protein may promote cancer cell proliferation and metastasis, while protecting cancer cells from apoptosis. Mutations in this gene have been identified in human patients with Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. [provided by RefSeq, Aug 2017]
Entrez Gene ID
3315
UniProt ID
P04792
Alternative Names
CMT2F; HMN2B; HSP27; HSP28; Hsp25; SRP27; HS.76067; HEL-S-102
Function
Small heat shock protein which functions as a molecular chaperone probably maintaining denatured proteins in a folding-competent state (PubMed:10383393, PubMed:20178975).

Plays a role in stress resistance and actin organization (PubMed:19166925).

Through its molecular chaperone activity may regulate numerous biological processes including the phosphorylation and the axonal transport of neurofilament proteins (PubMed:23728742).
Biological Process
Anterograde axonal protein transport Source: UniProtKB
Cellular response to vascular endothelial growth factor stimulus Source: BHF-UCL
Chaperone-mediated protein folding Source: UniProtKB
Intracellular signal transduction Source: BHF-UCL
Negative regulation of apoptotic process Source: UniProtKB
Negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway Source: BHF-UCL
Negative regulation of protein kinase activity Source: BHF-UCL
Platelet aggregation Source: UniProtKB
Positive regulation of angiogenesis Source: BHF-UCL
Positive regulation of blood vessel endothelial cell migration Source: BHF-UCL
Positive regulation of endothelial cell chemotaxis Source: BHF-UCL
Positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway Source: BHF-UCL
Positive regulation of interleukin-1 beta production Source: BHF-UCL
Positive regulation of tumor necrosis factor production Source: BHF-UCL
Regulation of autophagy Source: ParkinsonsUK-UCL
Regulation of I-kappaB kinase/NF-kappaB signaling Source: BHF-UCL
Regulation of protein phosphorylation Source: UniProtKB
Regulation of translational initiation Source: ProtInc
Response to unfolded protein Source: ProtInc
Response to virus Source: UniProtKB
Retina homeostasis Source: UniProtKB
Cellular Location
Cytoplasm; Spindle; Nucleus. Cytoplasmic in interphase cells. Colocalizes with mitotic spindles in mitotic cells. Translocates to the nucleus during heat shock and resides in sub-nuclear structures known as SC35 speckles or nuclear splicing speckles.
Involvement in disease
Charcot-Marie-Tooth disease 2F (CMT2F):
A dominant axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. Onset of Charcot-Marie-Tooth disease type 2F is between 15 and 25 years with muscle weakness and atrophy usually beginning in feet and legs (peroneal distribution). Upper limb involvement occurs later.
Neuronopathy, distal hereditary motor, 2B (HMN2B):
A neuromuscular disorder. Distal hereditary motor neuronopathies constitute a heterogeneous group of neuromuscular disorders caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. The overall clinical picture consists of a classical distal muscular atrophy syndrome in the legs without clinical sensory loss. The disease starts with weakness and wasting of distal muscles of the anterior tibial and peroneal compartments of the legs. Later on, weakness and atrophy may expand to the proximal muscles of the lower limbs and/or to the distal upper limbs.
PTM
Phosphorylated upon exposure to protein kinase C activators and heat shock (PubMed:8325890). Phosphorylation by MAPKAPK2 and MAPKAPK3 in response to stress dissociates HSPB1 from large small heat-shock protein (sHsps) oligomers and impairs its chaperone activity and ability to protect against oxidative stress effectively. Phosphorylation by MAPKAPK5 in response to PKA stimulation induces F-actin rearrangement (PubMed:1332886, PubMed:8093612, PubMed:19166925).
More Infomation

Wang, L., Wu, S., He, H., Ai, K., Xu, R., Zhang, L., & Zhu, X. (2022). CircRNA-ST6GALNAC6 increases the sensitivity of bladder cancer cells to erastin-induced ferroptosis by regulating the HSPB1/P38 axis. Laboratory Investigation, 102(12), 1323-1334.

Lu, S., Hu, J., Arogundade, O. A., Goginashvili, A., Vazquez-Sanchez, S., Diedrich, J. K., ... & Cleveland, D. W. (2022). Heat-shock chaperone HSPB1 regulates cytoplasmic TDP-43 phase separation and liquid-to-gel transition. Nature cell biology, 24(9), 1378-1393.

Alexander, C. C., Munkáscy, E., Tillmon, H., Fraker, T., Scheirer, J., Holstein, D., ... & Rodriguez, K. A. (2022). HspB1 overexpression improves life span and stress resistance in an invertebrate model. The Journals of Gerontology: Series A, 77(2), 268-275.

Liu, X., Xiao, W., Jiang, Y., Zou, L., Chen, F., Xiao, W., ... & Zhu, Y. (2021). Bmal1 regulates the redox rhythm of HSPB1, and homooxidized HSPB1 attenuates the oxidative stress injury of cardiomyocytes. Oxidative Medicine and Cellular Longevity, 2021, 1-16.

Gonçalves, C. C., Sharon, I., Schmeing, T. M., Ramos, C. H., & Young, J. C. (2021). The chaperone HSPB1 prepares protein aggregates for resolubilization by HSP70. Scientific reports, 11(1), 17139.

Muranova, L. K., Sudnitsyna, M. V., Strelkov, S. V., & Gusev, N. B. (2020). Mutations in HspB1 and hereditary neuropathies. Cell Stress and Chaperones, 25, 655-665.

Baughman, H. E., Pham, T. H. T., Adams, C. S., Nath, A., & Klevit, R. E. (2020). Release of a disordered domain enhances HspB1 chaperone activity toward tau. Proceedings of the National Academy of Sciences, 117(6), 2923-2929.

Haidar, M., Asselbergh, B., Adriaenssens, E., De Winter, V., Timmermans, J. P., Auer-Grumbach, M., ... & Timmerman, V. (2019). Neuropathy-causing mutations in HSPB1 impair autophagy by disturbing the formation of SQSTM1/p62 bodies. Autophagy, 15(6), 1051-1068.

Wang, Y., Liu, J., Kong, Q., Cheng, H., Tu, F., Yu, P., ... & Liu, L. (2019). Cardiomyocyte-specific deficiency of HSPB1 worsens cardiac dysfunction by activating NFκB-mediated leucocyte recruitment after myocardial infarction. Cardiovascular research, 115(1), 154-167.

Baughman, H. E., Clouser, A. F., Klevit, R. E., & Nath, A. (2018). HspB1 and Hsc70 chaperones engage distinct tau species and have different inhibitory effects on amyloid formation. Journal of Biological Chemistry, 293(8), 2687-2700.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-HSPB1 Recombinant Antibody (CB483A)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Learn more

Documents

Request bulk or custom quoteOnline Inquiry
Second antibody and isotype control

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Online Inquiry